Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis

Brigida Anna Maiorano,Domenica Lorusso,Mauro Francesco Pio Maiorano,Evaristo Maiello,Massimo Di Maio

doi:10.1136/ijgc-2022-003614

Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis

Brigida Anna Maiorano, Domenica Lorusso + Show 3 more

Open Access

https://doi.org/10.1136/ijgc-2022-003614

Copy DOI

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society	Publication Date: Oct 13, 2022
Citations: 10	License type: open-access

Affiliation: Istituti di Ricovero e Cura a Carattere Scientifico, Casa Sollievo della Sofferenza, Agostino Gemelli University Polyclinic, Polytechnic University of Bari, University of Bari Aldo Moro, University of Turin

#PARP Inhibitors In Patients #Advanced Ovarian Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

BackgroundPoly-(ADP-ribose)-polymerase (PARP) inhibitors have shown to be effective as maintenance treatment in patients with advanced ovarian cancer. Although most ovarian cancers develop after age 65, older patients are often under-represented...

Full Text